Jpmorgan Chase & CO A Ikido Pharma Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 9 shares of AIKI stock, worth $34. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 8
12.5%
Holding current value
$34
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AIKI
# of Institutions
15Shares Held
461KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA193KShares$734,8890.0% of portfolio
-
Black Rock Inc. New York, NY72.5KShares$275,5720.0% of portfolio
-
Geode Capital Management, LLC Boston, MA46.1KShares$175,2210.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny45.9KShares$174,5180.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX39.8KShares$151,3650.0% of portfolio
About AIkido Pharma Inc.
- Ticker AIKI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,485,100
- Market Cap $20.8M
- Description
- AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...